系统性红斑狼疮家族史与自身免疫病风险:丹麦全国队列研究1977-2013
该研究基于丹麦全国登记系统,纳入5 237 319名居民并随访1977至2013年,评估SLE患者亲属中SLE及其他自身免疫病的相对风险。结果显示SLE患者一级亲属的SLE风险显著升高(HR=10.3),其他自身免疫病风险亦轻度升高。
要点
- SLE患者一级亲属的SLE风险显著升高(HR=10.3,95%CI 8.25-12.9)。
- SLE患者一级亲属的RA风险升高(HR=1.64,95%CI 1.35-1.99)。
- SLE患者一级亲属的其他自身免疫病风险升高(HR=2.08,95%CI 1.88-2.31)。
核心结论
- SLE家族史与SLE风险明显升高相关,并与RA及其他自身免疫病风险轻度升高相关。
研究设计与样本
- 丹麦全国队列研究,通过民事登记系统纳入5 237 319名居民,经亲子链接关联亲属,1977至2013年通过国家患者登记系统随访SLE及其他自身免疫病,双生子合子型通过丹麦双生子登记确定,采用Cox比例风险回归计算HR及95%CI。
主要发现
- 随访117.5百万人年期间,3612人因SLE住院。
- SLE患者一级亲属的SLE风险HR=10.3(95%CI 8.25-12.9,n=80),二级或三级亲属HR=3.60(95%CI 2.20-5.90,n=16)。
- SLE患者一级亲属任何自身免疫病风险HR=1.51(95%CI 1.41-1.62,n=785),二级或三级亲属HR=1.28(95%CI 1.18-1.39,n=582)。
- SLE患者一级亲属中,RA风险HR=1.64(95%CI 1.35-1.99,n=103),IBD风险HR=1.21(95%CI 1.02-1.43,n=130),1型糖尿病风险HR=1.23(95%CI 1.01-1.48,n=106)。
- 其他自身免疫病风险在一级亲属中HR=2.08(95%CI 1.88-2.31,n=371),二级或三级亲属中HR=1.38(95%CI 1.23-1.54,n=313)。
临床怎么用
- 对SLE患者一级亲属应关注SLE及RA等其他自身免疫病的风险升高,临床评估时可考虑家族史信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To provide population-based estimates of relative risk of SLE and other autoimmune diseases (ADs) in relatives of SLE patients. METHODS: A cohort of 5 237 319 Danish residents identified through the Civil Registration System was coupled to their relatives through the parental link and followed for SLE and other ADs between 1977 and 2013 through linkage to the National Patient Register. Twin zygosity was established through the Danish Twin Registry. Hazard ratios (HRs) with 95% CIs were calculated using Cox proportional hazards regression analyses. RESULTS: During 117.5 million person-years of follow-up, 3612 persons were hospitalized with SLE. HRs of SLE were high among first-degree (HR = 10.3; 95% CI: 8.25, 12.9; n = 80) and second- or third-degree relatives of SLE patients (HR = 3.60; 95% CI: 2.20, 5.90; n = 16). HRs for any AD were elevated in first-degree (HR = 1.51; 95% CI: 1.41, 1.62; n = 785) and second- or third-degree relatives of SLE patients (HR = 1.28; 95% CI: 1.18, 1.39; n = 582). Among individuals with SLE-affected first-degree relatives, the risk was significantly increased for RA (HR = 1.64; 95% CI: 1.35, 1.99; n = 103), IBD (HR = 1.21; 95% CI: 1.02, 1.43; n = 130) and type 1 diabetes mellitus (HR = 1.23; 95% CI: 1.01, 1.48; n = 106). Risk of other ADs was significantly increased both among SLE-affected first-degree (HR = 2.08; 95% CI: 1.88, 2.31; n = 371) and second- or third-degree relatives (HR = 1.38; 95% CI: 1.23, 1.54; n = 313). CONCLUSION: Family history of SLE is associated with a clearly elevated risk of SLE and, to a much lesser degree, of RA and other ADs.
引用
- Ulff-Møller CJ, Simonsen J, Kyvik KO, et al. Family history of systemic lupus erythematosus and risk of autoimmune disease: Nationwide Cohort Study in Denmark 1977-2013. Rheumatology (Oxford). 2017. PMID: 28339674. doi:10.1093/rheumatology/kex005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。